As CHD1L is known to be implicated in the DDR by remodeling the chromatin, we hypothesized that the inhibition of CHD1L should potentiate DNA damage caused by DNA damaging drugs in CRC. The gene discussed is CHD1L; the disease is colorectal carcinoma.